FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+34.56%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$1.99M
AUM Growth
+$1.99M
(-100%)
Cap. Flow
-$1.31B
Cap. Flow
% of AUM
-65,864.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
43
New
–
Increased
–
Reduced
2
Closed
41
Top Buys
No buys this quarter
Top Sells
| 1 |
Arcutis Biotherapeutics
ARQT
|
$175M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$115M |
| 3 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
$70.4M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$60.7M |
| 5 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$60M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
1
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.75M | 88.13% | 54,654 -1,210,207 | -96% | -$38.8M |
|
|
ALNA
2
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $236K | 11.87% | 1,019,288 -632,069 | -38% | -$146K |
|
3
Aclaris Therapeutics
ACRS
$209M
| – | – | -408,329 | Closed | -$5.94M |
|
4
AnaptysBio
ANAB
$569M
| – | – | -899,700 | Closed | -$31.3M |
|
|
5
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – | -8,434,232 | Closed | -$175M |
|
6
Arvinas
ARVN
$568M
| – | – | -163,763 | Closed | -$13.5M |
|
|
AUTL
7
Autolus Therapeutics
AUTL
$399M
| – | – | -3,746,857 | Closed | -$19.4M |
|
|
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – | -951,814 | Closed | -$7.69M |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$511M
| – | – | -555,240 | Closed | -$33.8M |
|
10
Cogent Biosciences
COGT
$1.69B
| – | – | -1,774,891 | Closed | -$15.2M |
|
11
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – | -1,384,293 | Closed | -$39.3M |
|
12
ESSA Pharma
EPIX
$11.4M
| – | – | -543,470 | Closed | -$7.72M |
|
13
Immunovant
IMVT
$2.56B
| – | – | -585,759 | Closed | -$4.99M |
|
14
Iovance Biotherapeutics
IOVA
$807M
| – | – | -1,747,622 | Closed | -$33.4M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| – | – | -1,305,087 | Closed | -$17.3M |
|
16
Krystal Biotech
KRYS
$4.27B
| – | – | -771,250 | Closed | -$53.9M |
|
17
Mirum Pharmaceuticals
MIRM
$3.71B
| – | – | -3,566,912 | Closed | -$56.9M |
|
18
Merus
MRUS
$4.98B
| – | – | -559,179 | Closed | -$17.8M |
|
19
Passage Bio
PASG
$22.7M
| – | – | -5,009,219 | Closed | -$31.8M |
|
20
Vaxcyte
PCVX
$4B
| – | – | -2,309,554 | Closed | -$54.9M |
|
|
21
Phathom Pharmaceuticals
PHAT
$864M
| – | – | -5,827,415 | Closed | -$115M |
|
22
Replimune Group
REPL
$422M
| – | – | -650,862 | Closed | -$17.6M |
|
23
Regenxbio
RGNX
$451M
| – | – | -235,809 | Closed | -$7.71M |
|
|
SLN
24
Silence Therapeutics
SLN
$227M
| – | – | -886,173 | Closed | -$21.2M |
|
|
25
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – | -2,772,062 | Closed | -$60.7M |
|